DK93791D0 - Nye heterocykliske carboxylsyrer - Google Patents

Nye heterocykliske carboxylsyrer

Info

Publication number
DK93791D0
DK93791D0 DK91937A DK93791A DK93791D0 DK 93791 D0 DK93791 D0 DK 93791D0 DK 91937 A DK91937 A DK 91937A DK 93791 A DK93791 A DK 93791A DK 93791 D0 DK93791 D0 DK 93791D0
Authority
DK
Denmark
Prior art keywords
carboxylic acids
heterocyclic carboxylic
new heterocyclic
compounds
new
Prior art date
Application number
DK91937A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK91937A priority Critical patent/DK93791D0/da
Publication of DK93791D0 publication Critical patent/DK93791D0/da
Priority to DK92910899.1T priority patent/DK0585314T3/da
Priority to AT92910899T priority patent/ATE143009T1/de
Priority to ES92910899T priority patent/ES2094357T3/es
Priority to DE69213935T priority patent/DE69213935T2/de
Priority to EP92910899A priority patent/EP0585314B1/en
Priority to US07/882,788 priority patent/US5348965A/en
Priority to PCT/DK1992/000155 priority patent/WO1992020658A1/en
Priority to AU17837/92A priority patent/AU665761B2/en
Priority to CA2102811A priority patent/CA2102811A1/en
Priority to JP4509775A priority patent/JPH06507616A/ja
Priority to NZ242759A priority patent/NZ242759A/en
Priority to IL10188792A priority patent/IL101887A/en
Priority to ZA923556A priority patent/ZA923556B/xx
Priority to FI935064A priority patent/FI103116B/fi
Priority to NO934159A priority patent/NO300211B1/no
Priority to GR960403213T priority patent/GR3021822T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK91937A 1991-05-17 1991-05-17 Nye heterocykliske carboxylsyrer DK93791D0 (da)

Priority Applications (17)

Application Number Priority Date Filing Date Title
DK91937A DK93791D0 (da) 1991-05-17 1991-05-17 Nye heterocykliske carboxylsyrer
JP4509775A JPH06507616A (ja) 1991-05-17 1992-05-14 新規ヘテロ環状カルボン酸
US07/882,788 US5348965A (en) 1991-05-17 1992-05-14 N-substituted azaheterocyclic carboxylic acids
AU17837/92A AU665761B2 (en) 1991-05-17 1992-05-14 Novel heterocyclic carboxylic acids
ES92910899T ES2094357T3 (es) 1991-05-17 1992-05-14 Nuevos acidos carboxilicos heterociclicos.
DE69213935T DE69213935T2 (de) 1991-05-17 1992-05-14 Neue heterocyclische carbonsäuren
EP92910899A EP0585314B1 (en) 1991-05-17 1992-05-14 Novel heterocyclic carboxylic acids
DK92910899.1T DK0585314T3 (da) 1991-05-17 1992-05-14
PCT/DK1992/000155 WO1992020658A1 (en) 1991-05-17 1992-05-14 Novel heterocyclic carboxylic acids
AT92910899T ATE143009T1 (de) 1991-05-17 1992-05-14 Neue heterocyclische carbonsäuren
CA2102811A CA2102811A1 (en) 1991-05-17 1992-05-14 Novel heterocyclic carboxylic acids
ZA923556A ZA923556B (en) 1991-05-17 1992-05-15 Heterocyclic carboxylic acids
NZ242759A NZ242759A (en) 1991-05-17 1992-05-15 N-substituted azaheterocyclic carboxylic acid derivatives; preparation and pharmaceutical compositions thereof
IL10188792A IL101887A (en) 1991-05-17 1992-05-15 Heterocyclic carboxylic acids their preparation and pharmaceutical compositions containing them
FI935064A FI103116B (fi) 1991-05-17 1993-11-16 Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi
NO934159A NO300211B1 (no) 1991-05-17 1993-11-17 Heterosykliske karboksylsyrer, farmasöytiske preparater og anvendelse av karboksylsyrene til fremstilling av preparatene
GR960403213T GR3021822T3 (en) 1991-05-17 1996-11-28 Novel heterocyclic carboxylic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK91937A DK93791D0 (da) 1991-05-17 1991-05-17 Nye heterocykliske carboxylsyrer

Publications (1)

Publication Number Publication Date
DK93791D0 true DK93791D0 (da) 1991-05-17

Family

ID=8099201

Family Applications (2)

Application Number Title Priority Date Filing Date
DK91937A DK93791D0 (da) 1991-05-17 1991-05-17 Nye heterocykliske carboxylsyrer
DK92910899.1T DK0585314T3 (da) 1991-05-17 1992-05-14

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92910899.1T DK0585314T3 (da) 1991-05-17 1992-05-14

Country Status (16)

Country Link
US (1) US5348965A (da)
EP (1) EP0585314B1 (da)
JP (1) JPH06507616A (da)
AT (1) ATE143009T1 (da)
AU (1) AU665761B2 (da)
CA (1) CA2102811A1 (da)
DE (1) DE69213935T2 (da)
DK (2) DK93791D0 (da)
ES (1) ES2094357T3 (da)
FI (1) FI103116B (da)
GR (1) GR3021822T3 (da)
IL (1) IL101887A (da)
NO (1) NO300211B1 (da)
NZ (1) NZ242759A (da)
WO (1) WO1992020658A1 (da)
ZA (1) ZA923556B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK74693D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
DK74393D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
DK74493D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
IL112223A0 (en) * 1994-01-04 1995-03-30 Novo Nordisk As Pharmaceutical compositions for the treatment of neurological inflammatory conditions
US5698551A (en) * 1995-04-07 1997-12-16 Novo Nordisk A/S Heterocyclic compounds
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
AU1138397A (en) * 1995-12-15 1997-07-14 Novo Nordisk A/S Novel method
AU7907298A (en) * 1997-06-25 1999-01-19 Novo Nordisk A/S Novel heterocyclic compounds
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
US6468996B1 (en) * 1998-10-21 2002-10-22 Novo Nordisk A/S Substituted hetero-polycyclic compounds as PPARα and PPARγ activators
CN1382441A (zh) * 2002-05-21 2002-12-04 中国科学院上海生命科学研究院 γ-氨基丁酸转运蛋白抑制剂在制备镇痛药物中的应用
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL99690C (da) * 1956-11-15
BE560750A (da) * 1957-07-26
CH368178A (de) * 1958-09-10 1963-03-31 Geigy Ag J R Verfahren zur Herstellung von neuen basisch substituierten heterocyclischen Verbindungen
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
FI864246A7 (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer

Also Published As

Publication number Publication date
NO934159L (no) 1993-11-17
IL101887A0 (en) 1992-12-30
FI935064A0 (fi) 1993-11-16
EP0585314B1 (en) 1996-09-18
FI103116B1 (fi) 1999-04-30
NO934159D0 (no) 1993-11-17
DE69213935T2 (de) 1997-03-27
ATE143009T1 (de) 1996-10-15
IL101887A (en) 1996-10-16
FI103116B (fi) 1999-04-30
WO1992020658A1 (en) 1992-11-26
FI935064L (fi) 1993-11-16
DE69213935D1 (en) 1996-10-24
EP0585314A1 (en) 1994-03-09
NO300211B1 (no) 1997-04-28
AU665761B2 (en) 1996-01-18
ES2094357T3 (es) 1997-01-16
ZA923556B (en) 1993-01-27
CA2102811A1 (en) 1992-11-26
GR3021822T3 (en) 1997-02-28
DK0585314T3 (da) 1997-05-05
AU1783792A (en) 1992-12-30
US5348965A (en) 1994-09-20
JPH06507616A (ja) 1994-09-01
NZ242759A (en) 1995-03-28

Similar Documents

Publication Publication Date Title
NO934159D0 (no) Nye heterosykliske karboksylsyrer
MX9803753A (es) Acidos alfa-iminohidroxamicos y -carboxilicos n-sustituidos ciclicos y heterociclicos.
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
MX9603520A (es) Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
ES2096312T3 (es) Derivado de quinuclidina como antagonista de la sustancia p.
EP0671162A3 (en) Amphoteric compositions and polymer forms of alpha-hydroxy acids, and their therapeutic use.
RU94015838A (ru) Производные бензофуранил- или бензотиофенилалкан-карбоновой кислоты, смесь их изомеров или отдельные изомеры и их соли
GEP19991706B (en) (54) Heteroarylpiperidines, Pyrrolidines and Piperazines and Their Use As Antipsychotics and Analgetics
EP0676964A4 (en) NITROSYLATION OF PROTEIN-SH GROUPS AND RESIDUES OF AMINO ACID AS A THERAPEUTIC MEASURE.
FR2677019B1 (fr) Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
MX9304787A (es) Prodrogas de acidos de imidazolcarboxilicos y composiciones farmaceuticasque las contienen.
NO178398C (no) Piperidin derivater og farmasöytisk formulering
RU94031161A (ru) Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов
DE69400334D1 (de) Diaminsalze von clavulansäure
FI954614A0 (fi) Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina
NO955263L (no) N-substituerte azaheterosykliske karboksylsyrer og estere derav
NO921906D0 (no) Nye 2-amino-5-cyano-1,4-dihydropyridiner, deres fremstilling og anvendelse i legemidler
NO982863L (no) Nye forbindelser med analgetisk effekt
EP0618812A4 (en) USE OF PROTEASE NEXIN-I AS ANTI-INFLAMMATORY.
ATE169922T1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
FR2672888B1 (fr) Nouvelles urees et thiourees, leur preparation et leur application en therapeutique.
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
FR2663631B1 (fr) Procede d'esterification des acides hydroxybenzoiques.
IT1224250B (it) Associzione del depiprazolo con la morfina
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment